OpenAI Acquires Orchestra Bio to Expand Life Sciences AI Capabilities
OpenAI has acquired Orchestra Bio, an AI biotech software startup, to accelerate its Rosalind life sciences research platform and compete in pharmaceutical automation.
OpenAI has acquired Orchestra Bio, an AI biotech software startup, to accelerate its Rosalind life sciences research platform and compete in pharmaceutical automation.